Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE

Eosinophils & MOA NUCALA (mepolizumab) for CRSwNP

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up - Desrosiers - International Forum of Allergy & Rhinology - Wiley Online Library

Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis - ScienceDirect

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis - Fokkens - 2023 - Allergy - Wiley Online Library

Study Designs NUCALA (mepolizumab) for HCPs

FDA approves GSK's Nucala for use in adults with chronic rhinosinusitis with nasal polyps - PharmaLive

Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis - The Journal of Allergy and Clinical Immunology: In Practice

PDF] Chronic Rhinosinusitis with Nasal Polyps.

Biologic therapies for chronic rhinosinusitis with nasal polyps: a new paradigm

Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count - ScienceDirect

Comorbidity Data NUCALA (mepolizumab) for HCPs

Mepolizumab reduces risk for repeat surgery for chronic rhinosinusitis with nasal polyps

Biomedicines, Free Full-Text